GCP
OMIC

GSA Capital Partners’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

GSA Capital Partners’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,503
Closed -$62K – 2026
2023
Q2 		$62K Sell
2,503
-4,687
-65% -$137K 0.01% 1411
2023
Q1 		$261K Buy
7,190
+4,123
+134% +$253K 0.03% 1112
2022
Q4 		$185K Buy
3,067
+1,711
+126% +$115K 0.02% 1206
2022
Q3 		$102K Buy
+1,356
New +$142K 0.01% 1362

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GSA Capital Partners's OMIC Position: Q3 2023 in Review

GSA Capital Partners sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2023, closing a stake of 2,503 shares — an estimated $62K sold.

GSA Capital Partners first reported a position in OMIC in Q3 2022 and held it in 4 quarters. The position peaked at $261K in Q1 2023. 48 funds tracked by Wall St. Rank hold OMIC as of Q3 2023.

  • GSA Capital Partners reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • GSA Capital Partners sold 2,503 Singular Genomics Systems, Inc. Common Stock shares in Q3 2023, an estimated $62K.
  • GSA Capital Partners first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • GSA Capital Partners's Singular Genomics Systems, Inc. Common Stock position peaked at $261K in Q1 2023.
  • 48 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2023.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.